Cargando…
Clonal haematopoiesis of indeterminate potential‐related mutations and outcome in dilated and ischaemic cardiomyopathy
AIMS: Clonal haematopoiesis of indeterminate potential (CHIP)‐associated mutation is a risk factor for the development of ischaemic cardiomyopathy (ICM), but its association with non‐ischaemic dilated cardiomyopathy (DCM) remains unclear. We aimed to determine the prevalence of CHIP in patients with...
Autores principales: | Wu, Jasmine M.F., Bekfani, Tarek, Hinze, Anna, Westphal, Julian Georg, Steinacker, Berit, Zeller, Max, Hartmann, Charlotte, Möbius‐Winkler, Sven, Hochhaus, Andreas, Schulze, P. Christian, Ernst, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773636/ https://www.ncbi.nlm.nih.gov/pubmed/35979940 http://dx.doi.org/10.1002/ehf2.14115 |
Ejemplares similares
-
Interplay between chronic inflammation and clonal haematopoiesis of indeterminate potential in Behçet’s disease
por: Park, Jihye, et al.
Publicado: (2023) -
Clonal haematopoiesis of indeterminate potential: intersections between inflammation, vascular disease and heart failure
por: Mooney, Leanne, et al.
Publicado: (2021) -
Clonal haematopoiesis of indeterminate potential: associations with heart failure incidence, clinical parameters and biomarkers
por: Shi, Canxia, et al.
Publicado: (2022) -
Germline risk of clonal haematopoiesis
por: Silver, Alexander J., et al.
Publicado: (2021) -
Clonal haematopoiesis of indeterminate potential and impaired kidney function—A Danish general population study with 11 years follow‐up
por: Larsen, Morten K., et al.
Publicado: (2022)